Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer Points

The regimen consisting of carboplatin and paclitaxel represents the backbone of ovarian cancer treatment. Here, we reflect on our experience administering the carboplatin/paclitaxel regimen to scores of ovarian cancer patients over the past decade and a half.

Source: CancerNetwork - August 15, 2018 Category: Cancer & Oncology Authors: Leslie R. Boyd, MD, Franco M. Muggia, MD Source Type: news